HA TECH is developing a range of testing kits and reagents for both laboratory and point of care testing, including for ‘COVID-19’. The company has launched a multi-gene target SARS-CoV-2 RT-PCR kit that is one of the fastest available globally.
Diagnostic Products under Development
1. RT-PCR Multiplex Combo kit for testing SARS-CoV-2, Influenza and RSV Virus
2. RT-PCR Multiplex Combo kit for differentiating Dengue, Chikungunya, Malaria and Zika virus
3. Rapid SARS-CoV-2 point of care test.
Research also begun for other Respiratory & STI Panels
HA TECH is collaborating with a world leading research organization to develop biotherapeutic drugs. The company is developing a number of API products internally and via commercial partnership including: Cardiovascular, Antidiabetic, Anti-Ulcerant and Oncology drugs. The company is concentrating on the development of a key product range in Sydney and full-scale manufacturing in South East Asia, initially in Bangladesh.